Composite Polypeptide Metal Binding Motif Site-Specific Bioconjugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioconjugation methods lack chemoselectivity and efficiency in conjugating functional elements to specific sites on biomolecules, resulting in heterogeneous products and inefficient drug-to-antibody ratios.
Innovation Solution
A composite polypeptide with a metal binding motif, such as CX1X2HA, is used to form a complex with a zinc ion, enabling site-specific chemical conjugation of functional elements like cytotoxic drugs or radionuclides through the sulfhydryl group of cysteine residues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If random conjugation reactions are used to attach functional elements to biomolecules, then the conjugation process is simple, but the product heterogeneity increases and chemoselectivity is lost
Solution Approach 1:
The patent introduces a metal binding motif (such as HCX2X1Zn, where X1 and X2 are specific amino acids) as a preliminary structural feature on the biomolecule surface. This motif pre-positions a metal ion at a specific location, which then serves as a template for subsequent chemoselective conjugation of functional elements, achieving site-specific attachment without random reactions
Solution Approach 2:
The patent uses a metal ion (such as Zn2+) as an intermediary component that mediates between the biomolecule and the functional element. The metal ion binds to the metal binding motif on the biomolecule and simultaneously coordinates with the functional element, enabling chemoselective conjugation at a specific site while maintaining process simplicity
2Productivity
If multiple amino acid residues are used for conjugation, then the reaction efficiency increases, but the drug-to-antibody ratio heterogeneity increases
Solution Approach 1:
The patent creates a localized conjugation site by introducing a metal binding motif at a specific location on the biomolecule. This motif concentrates the conjugation capability to a single defined region, ensuring that functional elements attach at a predetermined site with controlled stoichiometry, thereby achieving uniform drug-to-antibody ratios while maintaining high reaction efficiency through the catalytic effect of the metal ion
3Ease of operation
If conventional conjugation methods are used, then the process is straightforward, but the therapeutic efficacy is reduced due to product heterogeneity
Solution Approach 1:
The patent changes the chemical parameters of the conjugation system by introducing a metal ion with specific coordination properties. This parameter change enables chemoselective reactions under mild conditions, producing homogeneous bioconjugates with defined drug-to-antibody ratios, thereby improving therapeutic efficacy while maintaining operational simplicity through a single-step conjugation process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the formation of homogeneous bioconjugates with improved targeting and therapeutic efficacy by facilitating site-specific conjugation, enhancing the pharmacokinetic profile and therapeutic effect of the molecular constructs.
Implementation Method 1
a metal binding motif, which is capable of forming a complex with a zinc ion under suitable conditions
Data Source
AI summary
Disclosed herein are composite polypeptide. According to various embodiments, the composite polypeptide includes a parent polypeptide and a metal binding motif capable of forming a complex with a metal cation. The composite polypeptide may be conjugated with a linker unit having a plurality of functional elements to form a multi-functional molecular construct. Alternatively, multiple composite polypeptides may be conjugated to a linker unit to form a molecular construct, or a polypeptide bundle. Linker units suitable for conjugating with the composite polypeptide having the metal binding motif are also disclosed.